🔗 Permalink

Inventor profile of:

Benjamin S. Bleier

City:

Weston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-07-31

Top Assignees for applications by Benjamin S. Bleier

The entities that hold a legal rights for patent applications filed by inventor Bleier Benjamin S.:

Massachusetts Eye and Ear Infirmary 9 Boston, MA United States
Massachusetts Eye & Ear Infirmary 4 Boston, MA United States
MASSACHUSETTS EYE & EAR INFIRMARY 1 Boston, MA United States

Recent patent applications by Bleier Benjamin S.

Benjamin S. Bleier from Weston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-31

US20250244341A1

Physics

Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis

#2 | 2024-06-06

US20240181231A1

Human necessities

SUBMUCOSAL IMPLANTABLE DRUG DELIVERY APPARATUSES, SYSTEMS, AND METHODS

#3 | 2024-05-09

US20240148823A1

Human necessities

Treatment of rhinosinusitis with P-glycoprotein inhibitors

#4 | 2023-07-20

US20230226008A1

Human necessities

Combination Verapamil and Mometasone Therapy for the treatment of Chronic Rhinosinusitis

#5 | 2023-05-25

US20230159659A1

Chemistry; metallurgy

INHIBITION OF CYSTATINS FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS

#6 | 2023-04-13

US20230111968A1

Physics

Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis

#7 | 2022-06-02

US20220168260A1

Human necessities

Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity

#8 | 2021-10-28

US20210330737A1

Human necessities

Treatment of rhinosinusitis with p-glycoprotein inhibitors

#9 | 2021-01-28

US20210023295A1

Human necessities

SUBMUCOSAL DRUG DELIVERY APPARATUSES, SYSTEMS, AND METHODS

#10 | 2020-06-25

US20200197481A1

Human necessities

Treatment of rhinosinusitis with P-glycoprotein inhibitors

#11 | 2019-03-21

US20190086426A1

Physics

Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis

#12 | 2017-12-07

US20170348384A1

Human necessities

Treatment of rhinosinusitis with P-glycoprotein inhibitors

#13 | 2016-07-07

US20160193286A1

Human necessities

Treatment of rhinosinusitis with P-glycoprotein inhibitors

#14 | 2016-07-07